HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanuel Itti Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

11/2023Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
1/2021Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
1/2021Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
1/2018Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma.
10/2012Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.
9/2012Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?
1/2012Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.
5/2011Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study.
12/2010Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.
11/2009Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanuel Itti Research Topics

Disease

13Amyloidosis
01/2023 - 01/2015
13Lymphoma (Lymphomas)
11/2022 - 08/2005
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 10/2007
12Neoplasms (Cancer)
02/2023 - 07/2003
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2012
7Macrophagic myofasciitis
10/2018 - 11/2011
5B-Cell Lymphoma (Lymphoma, B Cell)
05/2024 - 08/2007
4Cognitive Dysfunction
01/2018 - 11/2011
3Transthyretin-Related Hereditary Amyloidosis
10/2023 - 01/2021
3Neoplasm Metastasis (Metastasis)
04/2019 - 06/2006
2Neurofibromatoses (Neurofibromatosis)
02/2024 - 01/2016
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2024 - 01/2017
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
11/2022 - 01/2021
2Immunoglobulin Light-chain Amyloidosis
12/2021 - 01/2019
2Heart Failure
01/2021 - 01/2016
2Breast Neoplasms (Breast Cancer)
10/2019 - 06/2006
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2018 - 01/2018
2Fatigue
12/2017 - 01/2015
2Parkinsonian Disorders (Parkinsonism)
09/2016 - 12/2009
2Parkinson Disease (Parkinson's Disease)
07/2009 - 09/2007
2Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2007 - 01/2006
1Neurofibroma
02/2024
1Neurofibrosarcoma (MPNST)
02/2024
1Neurofibromatosis 1 (Neurofibromatosis Type I)
02/2024
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2024
1Glioblastoma (Glioblastoma Multiforme)
10/2023
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2022
1Infections
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Disease Progression
06/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Follicular Adenocarcinoma
01/2020
1Amenorrhea
10/2019
1Endocarditis
05/2019
1Paresis (Hemiparesis)
04/2019
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2019
1Circulating Neoplastic Cells
10/2018
1Anemia
01/2018
1Hodgkin Disease (Hodgkin's Disease)
01/2018
1Glioma (Gliomas)
01/2018
1Inflammation (Inflammations)
01/2018
1Liver Diseases (Liver Disease)
12/2017
1Liver Neoplasms (Liver Cancer)
12/2017
1Abdominal Pain (Pain, Abdominal)
12/2017

Drug/Important Bio-Agent (IBA)

18Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2024 - 07/2003
9Prealbumin (Transthyretin)IBA
01/2023 - 01/2015
7Rituximab (Mabthera)FDA Link
02/2023 - 01/2012
6Amyloid (Amyloid Fibrils)IBA
10/2023 - 01/2015
5Biomarkers (Surrogate Marker)IBA
10/2020 - 09/2012
4Aluminum Hydroxide (Algeldrate)FDA Link
10/2018 - 11/2011
3axicabtagene ciloleucelIBA
05/2024 - 10/2023
3fluorocholineIBA
01/2022 - 01/2018
3Contrast MediaIBA
10/2020 - 06/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2024 - 10/2012
2tafamidisIBA
12/2022 - 01/2021
2GemcitabineFDA Link
01/2022 - 01/2021
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 01/2021
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2015
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
07/2009 - 09/2007
2Deoxyglucose (2 Deoxy D glucose)IBA
08/2007 - 08/2005
1Vincristine (Oncovin)FDA LinkGeneric
02/2024
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024
1Prednisone (Sone)FDA LinkGeneric
02/2024
1Brentuximab VedotinIBA
02/2024
1romidepsin (FK228)FDA Link
02/2024
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Chlorambucil (Leukeran)FDA Link
11/2022
1NivolumabIBA
01/2022
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
12/2021
1FluoridesIBA
08/2021
1MCOIBA
01/2021
1obinutuzumabIBA
01/2021
1gadobenic acid (gadobenate dimeglumine)FDA Link
10/2020
1IodineIBA
01/2020
1Succimer (Dimercaptosuccinic Acid)FDA Link
01/2019
1Cell-Free Nucleic AcidsIBA
10/2018
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2018
1Amino AcidsFDA Link
01/2018
1IronIBA
01/2018
1C-Reactive ProteinIBA
01/2018
1Organophosphonates (Phosphonates)IBA
01/2018
1AcidsIBA
01/2018
1Yttrium-90IBA
12/2017
1CreatinineIBA
12/2017
1Sorafenib (BAY 43-9006)FDA Link
12/2017
1SirtuinsIBA
12/2017
1VaccinesIBA
09/2017

Therapy/Procedure

20Therapeutics
05/2024 - 07/2003
5Drug Therapy (Chemotherapy)
02/2024 - 01/2006
4Stem Cell Transplantation
05/2024 - 01/2021
4Radiotherapy
10/2023 - 12/2017
3Aftercare (After-Treatment)
01/2022 - 05/2011
3Liver Transplantation
01/2018 - 02/2016
1Combination Drug Therapy (Combination Chemotherapy)
01/2021
1Thyroidectomy
01/2020
1Neoadjuvant Therapy
10/2019
1Transcatheter Aortic Valve Replacement
05/2019
1Microspheres (Microsphere)
12/2017